Chembond Chemicals (CHEMBONDCH) Q2 FY27 Profit Slumps 55% Despite 31% Revenue Jump
Chembond's Q2 FY27 sales surged on strong demand, but a severe margin squeeze cut its net profit by more than half year-on-year.
Chembond Chemicals posted a 31% jump in Q2 FY27 revenue to ₹95.8 crore, but its net profit fell 55% to ₹3.3 crore. The collapse in profitability was driven by raw material cost inflation that the company could not fully pass on to customers.
For a specialty chemical maker like Chembond, the story is often told in margins. The company entered its second quarter with a history of strong volume growth but facing a post-war spike in the costs of key metals like zinc and molybdenum. The question was whether its contract renewals could pass those costs through. The answer, for this quarter, was a painful no.
Chembond's revenue grew a robust 31% year-on-year to ₹95.8 crore, and even rose 11% from the previous quarter. Yet its net profit collapsed by 55% from a year ago and 66% sequentially to just ₹3.3 crore. The net profit margin shrank to 3.4%, a drop of 640 basis points from last year and far below its trailing twelve-month average of 9.2%.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 95.77YoY +31% | 86.48 | 73.04 |
| Profit (₹ Cr) | 3.26YoY -55% | 9.55 | 7.19 |
| Net Profit Margin (%) | 3.4YoY -65% | 11.0 | 9.8 |
Why the top line didn't reach the bottom
The revenue growth, according to a report from Sector Alpha, was driven by a surge in volumes from new customers signed in recent quarters. The core Water Technologies segment, which contributes about 87% of revenue, has been the primary driver. However, this sales momentum ran headlong into a cost wall.
Reports from SAHI and Sector Alpha point to raw material cost inflation as the culprit. Management had warned of a 3-percentage-point margin squeeze heading into the year. The April 2026 contract renewal window, a critical moment to reprice deals, appears to have failed to fully offset the surge in costs for inputs like zinc and molybdenum.
The outlook for a margin recovery
The path forward hinges on pricing power. Sector Alpha notes that management secured temporary price increases from some private-sector customers and is rebidding public-sector contracts. The timeline for a recovery, if input costs stabilize, is estimated at two to three quarters, pointing to a potential improvement by the end of this fiscal year.
This plays out against a broader industry backdrop of recovery with constraints. A detailed analysis by DSIJ Insights describes an Indian chemical sector emerging from a downcycle, with volumes recovering but pricing power still limited by Chinese overcapacity. For Chembond, this means the demand environment is supportive, but the ability to reclaim lost profitability is its own, separate battle.
Key Points
- Revenue grew 31% year-on-year to ₹95.8 crore, demonstrating strong underlying demand, particularly in the Water Technologies segment.
- Net profit fell 55% YoY and 66% sequentially to ₹3.3 crore, as a severe margin squeeze overwhelmed sales growth.
- The net profit margin collapsed to 3.4%, down 640 basis points from the same quarter last year.
- Raw material cost inflation, which management could not fully pass on during contract renewals, was the primary driver of the profit decline.
- The balance sheet remains robust with zero debt, a current ratio of 5.1, and high interest cover, providing stability through the margin pressure.
Hexa Perspective
Chembond’s quarter lays bare the tension between volume growth and pricing power in a cost-inflationary environment. The company’s revenue trajectory confirms the strength of its market position and order book. Yet, its profitability has been hollowed out, with margins now sitting at less than a third of their trailing average.
The next few quarters will test management's ability to execute on its stated path to recovery. With a debt-free balance sheet, the company has the financial resilience to navigate this squeeze. Investors are left weighing the durability of the volume growth against the uncertainty of when, and by how much, margins can recover in a competitive market still capped by Chinese pricing pressure.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.